Nasopharyngeal carcinoma is characterised by distinct geographical distribution and is
particularly prevalent in east and southeast Asia. Epidemiological trends in the past decade�…

Epidemiological trends during the past decade suggest that although incidence of
nasopharyngeal carcinoma is gradually declining, even in endemic regions, mortality from�…

Incidence of nasopharyngeal carcinoma has remained high in endemic regions. Diagnosing
the disease in the early stages requires a high index of clinical acumen and, although most�…

Nasopharyngeal carcinoma of the undifferentiated subtype is endemic to southern China,
and patient prognosis has improved significantly over the past three decades because of�…

The past three decades have borne witness to many advances in the understanding of the
molecular biology and treatment of nasopharyngeal carcinoma (NPC), an Epstein–Barr virus�…

Nasopharyngeal carcinoma (NPC) is a unique disease endemic in Asia. It is etiologically
linked to the Epstein-Barr virus and is both radio-and chemo-sensitive. While radiotherapy�…

Nasopharyngeal carcinoma is endemic in Asia and is etiologically associated with Epstein–
Barr virus. Radiotherapy is the primary treatment modality. The role of systemic therapy has�…

With the improvement in local control achieved by more precise imaging and radiotherapy,
the predominant mode of failure for nasopharyngeal carcinoma is distant metastases�…

Nasopharyngeal carcinoma (NPC) is a distinct type of head and neck cancer. Approximately
70% of patients with newly diagnosed NPC present with locally advanced disease. Phase III�…

Nasopharyngeal carcinoma (NPC) differs from other head and neck cancers in its aetiology,
epidemiology and potential therapeutic options. Despite cure for the majority of the patients�…